Frozen resuscitation solution for multiple cytokine induced killer cells, and application thereof
A technology for killing cells and cytokines, which is applied in the direction of animal cells, vertebrate cells, and cell culture active agents. It can solve the problems of clinical application of unsuitable cell products, and achieve high induction differentiation efficiency, good cell activity, and fast proliferation rate. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0057] 1. PBMC recovery
[0058] (1) Peripheral blood mononuclear cells (PBMCs) cryopreserved in liquid nitrogen were taken out and rapidly thawed in a water bath at 37-42°C.
[0059] (2) The cells were treated with an equal volume of X-VIVO15 medium (referred to as group P) and an equal volume of recovery solution containing 2.5% HSA and 5% Dextran40 (referred to as group F1).
[0060] (3) Centrifuge, take the cells separately, count with a cell viability analyzer, and measure the cell viability.
[0061] 2. Induced into CIK cells
[0062] Cells in group P and group F1 were cultured statically for 24 hours in X-VIVO15 medium, respectively. Then, 1000U / ml IFN-γ and 2.5% Supgrow were added to the cell culture medium of the P group and the F1 group, after continuing to culture for 24 hours, 100ng / ml CD3, 1000U / ml IL-2, 1000U / ml IL-1α were added, Perform in vitro induction amplification.
[0063] 3. Calculate
[0064] Since the number of initial cells is inconsistent when re...
Embodiment 2
[0091] 1. Cord blood MNC resuscitation
[0092](1) The cryopreserved umbilical cord blood mononuclear cells (MNC) were taken out from liquid nitrogen and rapidly thawed in a water bath at 37-42°C.
[0093] (2) Use equal volumes of X-VIVO15 medium (referred to as P group), and equal volumes of resuscitation fluid containing 2.5% HSA and 5% Dextran40 (referred to as F1 group), 2.5% plasma, 5% Dextran40 Cells were treated in four ways with resuscitation solution (referred to as F2 group), resuscitation solution with 5% plasma and 5% Dextran40 (referred to as F3 group).
[0094] (3) Centrifuge, take the cells separately, and use a cell viability analyzer to count and measure the cell viability.
[0095] 2. Induced into CIK cells
[0096] The cells treated in groups P and F1-3 were cultured statically for 24 hours in X-VIVO15 medium, respectively. The cells treated in the P and F1-3 groups were treated by adding 1000U / ml IFN-γ and 2.5% Supgrow, and continued to culture for 24 ho...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com